Bio-Rad Laboratories (BIO-B) Change in Acquisitions & Divestments (2010 - 2026)

Bio-Rad Laboratories (BIO-B) has 17 years of Change in Acquisitions & Divestments data on file, last reported at $17.7 million in Q1 2026.

• Quarterly Change in Acquisitions & Divestments fell 9.23% year-over-year to $17.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $60.2 million (down 94.29% YoY) and the FY2025 annual result came in at $62.0 million, down 94.39% from the prior year.
• Change in Acquisitions & Divestments advanced to $17.7 million in Q1 2026 per BIO-B's latest filing, from -$584.2 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $601.0 million in Q3 2025 and bottomed at -$584.2 million in Q4 2025.
• The 5-year median for Change in Acquisitions & Divestments is $76.1 million (2023), against an average of $120.3 million.
• The widest annual swing landed in 2022, when Change in Acquisitions & Divestments jumped 12169.9%; it then slumped 384.28% in 2025.
• Tracing BIO-B's Change in Acquisitions & Divestments over 5 years: stood at $65.1 million in 2022, then jumped by 150.28% to $162.9 million in 2023, then increased by 26.18% to $205.5 million in 2024, then tumbled by 384.28% to -$584.2 million in 2025, then jumped by 103.03% to $17.7 million in 2026.
• Per Business Quant, the three latest BIO-B Change in Acquisitions & Divestments figures stand at $17.7 million (Q1 2026), -$584.2 million (Q4 2025), and $601.0 million (Q3 2025).

Peer Comparison